Rashed Dewan
Fortune : 572 691 $ au 30/06/2026
Fortune : 572 691 $ au 30/06/2026
Rashed Dewan is currently Chief Financial Officer at Profound Medical Corp.
since 2022.
Formerly, Mr. Dewan worked as Controller at Profound Medical, Inc. Mr. Dewan completed undergraduate studies at the University of Southern California.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PROFOUND MEDICAL CORP 0,24 % | 24/06/2026 | 86 119 ( 0,24 % ) | 572 691 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PROFOUND MEDICAL CORP. | Directeur Financier/CFO | 03/03/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Develops and commercializes a unique, minimally invasive treatment for prostate cancer | Comptroller/Controller/Auditor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Develops and commercializes a unique, minimally invasive treatment for prostate cancer | Health Technology |
Profound Medical Corp.
Profound Medical Corp. Medical SpecialtiesHealth Technology Develops and markets medical devices focused on prostate cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national